共有 2 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R031975-10mg | 10mg | 5~7个工作日 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
96% |
|
|
| 阿拉丁 | T127249-10mg | 10mg | 现货 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
≥96% |
|
|
| 阿拉丁 | T127249-50mg | 50mg | 期货,请咨询 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
≥96% |
|
|
| 阿拉丁 | T127249-5mg | 5mg | 期货,请咨询 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
≥96% |
|
|
| 凯为 | JZ008U9G-1mg | 1mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 凯为 | JZ008U9G-5mg | 5mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 凯为 | JZ008U9G-10mg | 10mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 凯为 | JZ008U9G-25mg | 25mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 凯为 | JZ008U9G-50mg | 50mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 凯为 | JZ008U9G-100mg | 100mg | 现货 |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,... (3S,4R)-4-Methyl-3-(methyl-7... |
96% |
|
|
| 毕得 | BD629888-5mg | 5mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-1mg | 1mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-10mg | 10mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-25mg | 25mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-50mg | 50mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-100mg | 100mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 毕得 | BD629888-250mg | 250mg | 现货 |
3-((3S,4R)-4-甲基-3-(甲基(7H-吡咯并... 3-((3S,4R)-4-Methyl-3-(methy... |
96% |
|
|
| 韶远 | SY235825-0.1g | 0.1g | 现货 |
3-[(3S,4R)-4-甲基-3-[甲基(7H-吡咯并... 3-[(3S,4R)-4-Methyl-3-[methy... |
≥95% |
|
|
| TRC | T528010-10mg | 10mg | 期货,请咨询 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
|
|
|
| TRC | T528010-1mg | 1mg | 期货,请咨询 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
|
|
|
| TRC | T528010-2.5mg | 2.5mg | 期货,请咨询 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
|
|
|
| 源叶 | B58037-10mg | 10mg | 期货,请咨询 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
98% |
|
|
| 源叶 | V31446-10mg | 10mg | 现货 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
≥96% |
|
|
| 源叶 | V31446-50mg | 50mg | 现货 |
(3S,4R)-Tofacitinib (3S,4R)-Tofacitini |
≥96% |
|
|
| Target Mol | T13427-25mg | 25 mg | 期货,请咨询 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
|
|
|
| Target Mol | T13427-50mg | 50 mg | 期货,请咨询 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
|
|
|
| Target Mol | T13427-100mg | 100 mg | 期货,请咨询 |
(3S,4R)-托法替尼 (3S,4R)-Tofacitini |
|
|
|
| QCC | QT060316 | 100mg | 4-6周 |
Tofacitinib Impurity P Tofacitinib Impurity P |
咨询 | 请联系客服购买! |